Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients.

Autor: Shrestha P; Li Ka Shing Cell and Gene Therapy Program, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.; Precision Oncology Program, Gene and Stem Cell Therapy Program, Centenary Institute, University of Sydney, Camperdown, Australia.; Medical Oncology, Calvary Mater Newcastle, Waratah, Australia., Kao S; Faculty of Medicine and Health, University of Sydney, Australia.; Medical Oncology, Chris O'Brien Lifehouse, Camperdown, Australia., Cheung VK; Faculty of Medicine and Health, University of Sydney, Australia.; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, Australia., Cooper WA; Faculty of Medicine and Health, University of Sydney, Australia.; Department of Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, Australia.; School of Medicine, University of Western Sydney, Australia., van Zandwijk N; Faculty of Medicine and Health, University of Sydney, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District, Camperdown, Australia.; Concord Repatriation General Hospital, Sydney Local Health District, Concord, Australia., Rasko JEJ; Li Ka Shing Cell and Gene Therapy Program, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.; Precision Oncology Program, Gene and Stem Cell Therapy Program, Centenary Institute, University of Sydney, Camperdown, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District, Camperdown, Australia., Yeo D; Li Ka Shing Cell and Gene Therapy Program, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.; Precision Oncology Program, Gene and Stem Cell Therapy Program, Centenary Institute, University of Sydney, Camperdown, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District, Camperdown, Australia.

Publikováno v: Molecular oncology [Mol Oncol] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.

Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer.

Autor: Ke H; Li Ka Shing Cell & Gene Therapy Program, The University of Sydney, Camperdown, 2050 NSW, Australia; Precision Oncology Laboratory, Gene and Stem Cell Therapy Program, Centenary Institute, The University of Sydney, Camperdown, 2050 NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050 NSW, Australia; Medical Oncology, Chris O'Brien Lifehouse, NSW 2050 Camperdown, Australia., Kao S; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050 NSW, Australia; Medical Oncology, Chris O'Brien Lifehouse, NSW 2050 Camperdown, Australia; Asbestos Diseases Research Institute, NSW 2139 Concord, Australia., van Zandwijk N; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050 NSW, Australia; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District (SLHD), Camperdown, 2050 NSW, Australia., Rasko JEJ; Li Ka Shing Cell & Gene Therapy Program, The University of Sydney, Camperdown, 2050 NSW, Australia; Precision Oncology Laboratory, Gene and Stem Cell Therapy Program, Centenary Institute, The University of Sydney, Camperdown, 2050 NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050 NSW, Australia; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District (SLHD), Camperdown, 2050 NSW, Australia. Electronic address: john.rasko@sydney.edu.au., Yeo D; Li Ka Shing Cell & Gene Therapy Program, The University of Sydney, Camperdown, 2050 NSW, Australia; Precision Oncology Laboratory, Gene and Stem Cell Therapy Program, Centenary Institute, The University of Sydney, Camperdown, 2050 NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050 NSW, Australia; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District (SLHD), Camperdown, 2050 NSW, Australia. Electronic address: dannel.yeo@sydney.edu.au.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Jun; Vol. 192, pp. 107829. Date of Electronic Publication: 2024 May 22.

The silent malignant mesothelioma epidemic: a call to action

Autor: van Zandwijk, N, Rasko, JEJ, George, AM, Frank, AL, Reid, G

Publikováno v: The Lancet Oncology. 23:1245-1248

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1693df7f16b8380e6f801fed2e42e5c9
https://doi.org/10.1016/s1470-2045(22)00269-8

Exon 20-Mutated NSCLC: Extending the Data Set to Allow the Recognition of Potential Causes.

Autor: van Zandwijk N; Royal Prince Alfred Hospital, Sydney Local Health District, Camperdown, Australia., Amos CI; Royal Prince Alfred Hospital, Sydney Local Health District, Camperdown, Australia., Røe OD; Royal Prince Alfred Hospital, Sydney Local Health District, Camperdown, Australia., Reid G; Royal Prince Alfred Hospital, Sydney Local Health District, Camperdown, Australia., Klebe S; Royal Prince Alfred Hospital, Sydney Local Health District, Camperdown, Australia.

Publikováno v: JTO clinical and research reports [JTO Clin Res Rep] 2023 Mar 15; Vol. 4 (4), pp. 100500. Date of Electronic Publication: 2023 Mar 15 (Print Publication: 2023).

Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients

Autor: Kappers, I., Belderbos, J.S.A., Burgers, J.A., van Zandwijk, N., Groen, H.J.M., Klomp, H.M.

Publikováno v: In Lung Cancer 2008 59(3):385-390